Evidence map›Paper›PMID 35157128›Full record

ReviewInternational journal of legal medicine2022

Postmortem CT pulmonary findings in SARS-CoV-2-positive cases: correlation with lung histopathological findings and autopsy results.

Laura Filograna, Simone Grassi, Guglielmo Manenti, Carlo Di Donna, Doriana Tatulli, Francesco Nardoni, Valentina Masini, Francesco Ausania, Vincenzo Maria Grassi, Roberto Floris and 4 more

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of legal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Laura FilogranaDepartment of Integrated Care Processes, Diagnostic Imaging Area, Tor Vergata University, PTV Policlinico Tor Vergata, Viale Oxford 81, 00133, FondazioneRome, Italy. laura.filograna@gmail.com.
Simone GrassiDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Guglielmo ManentiDepartment of Integrated Care Processes, Diagnostic Imaging Area, Tor Vergata University, PTV Policlinico Tor Vergata, Viale Oxford 81, 00133, FondazioneRome, Italy.
Carlo Di DonnaDepartment of Integrated Care Processes, Diagnostic Imaging Area, Tor Vergata University, PTV Policlinico Tor Vergata, Viale Oxford 81, 00133, FondazioneRome, Italy.
Doriana TatulliDepartment of Integrated Care Processes, Diagnostic Imaging Area, Tor Vergata University, PTV Policlinico Tor Vergata, Viale Oxford 81, 00133, FondazioneRome, Italy.
Francesco NardoniDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Valentina MasiniDepartment of Diagnostic Imaging, Oncological Radiotherapy and Hematology - Diagnostic Imaging Area, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Francesco AusaniaDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Vincenzo Maria GrassiDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Roberto FlorisDepartment of Integrated Care Processes, Diagnostic Imaging Area, Tor Vergata University, PTV Policlinico Tor Vergata, Viale Oxford 81, 00133, FondazioneRome, Italy.
Cesare ColosimoDepartment of Diagnostic Imaging, Oncological Radiotherapy and Hematology - Diagnostic Imaging Area, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Vincenzo ArenaDepartment of Woman and Child Health and Public Health, Area of Pathology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Vincenzo Lorenzo PascaliDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Antonio OlivaDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Francesco Vito, 1, 00168, Rome, Italy.
Policlinico Tor Vergata · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITAgostino Gemelli University Polyclinic · IT

Funding

università cattolica del sacro cuore Linea D1
6 · The paper itself

Abstract

introduction/purposePostmortem computed tomography (PMCT) is a valuable tool for analyzing the death of patients with SARS-CoV-2 infection. The purpose of this study was to investigate the correlation between PMCT lung findings in autopsy cadavers positive for SARS-CoV-2 infection and the severity of COVID-19 lung disease by histopathological analysis. MATERIALS AND

methodsWe reviewed chest PMCT findings, paying particular attention to the lung parenchyma, in 8 autopsy cases positive for SARS-CoV-2. Correlations between chest PMCT and histopathological findings were assessed. Clinical conditions and comorbidities were also recorded and discussed. The primary cause of death was finally considered.

resultsIn 6/8 cases, pulmonary PMCT findings were massive consolidation (4/8) and bilateral diffuse mixed densities with a crazy-paving pattern (2/8). These cases showed severe pulmonary signs of COVID-19 at histopathological analysis. In the remaining 2/8 cases, pulmonary PMCT findings were scant antideclive ground-glass opacities in prevalent gradient densities attributed to hypostasis. In 4/8 cases with massive consolidations, important comorbidities were noted. In 6/8 cases with severe pulmonary histopathological signs of lung COVID-19, autopsy found that the cause of death was cardiorespiratory failure. In the remaining 2/8 cases, histopathological analysis revealed lung alterations due to edema and some signs of SARS-CoV-2 infection; the cause of death was not attributed to SARS-CoV-2 infection (Table 1). DISCUSSION AND

conclusionChest PMCT findings correlate with the severity of COVID-19 lung disease at histopathology examination. According to our results, there may also be a relationship between cause of death and PMCT findings in COVID-19, which must be critically analyzed considering clinical antemortem data.

Indexed as

COVID-19SARS-CoV-2AutopsyHumansLungTomography, X-Ray ComputedCOVID-19Lung findingsPostmortem CTPulmonary histopathologySARS-CoV-2

Identifiers

PMID35157128
PMCPMC8853405
OpenAlexW4213044226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.